Quetiapine manufactured by Aurobindo is a generic version of Seroquel, originally developed by AstraZeneca [1]. Aurobindo's generic quetiapine is used to treat schizophrenia, bipolar disorder, and as an add-on treatment for major depressive disorder [2].
When can generic quetiapine be sold?
The patent protection for Seroquel (quetiapine fumarate) expired in the United States in 2012, allowing for the introduction of generic versions [1][3].
How does Aurobindo's quetiapine differ from Seroquel?
Both Aurobindo's generic quetiapine and brand-name Seroquel contain the same active ingredient, quetiapine fumarate, and are bioequivalent [2]. This means they are expected to have the same therapeutic effect and safety profile. The primary difference lies in the inactive ingredients and branding.
What conditions does generic quetiapine treat?
Aurobindo's quetiapine is indicated for the treatment of schizophrenia in adults and adolescents [2]. It is also used to manage manic episodes associated with bipolar I disorder in adults and children, depressive episodes associated with bipolar I disorder in adults, and as an adjunct treatment for major depressive disorder in adults who have an inadequate response to antidepressant therapy [2].
What are the side effects of quetiapine?
Common side effects of quetiapine can include drowsiness, dizziness, dry mouth, constipation, weight gain, and blurred vision [2]. More serious side effects may include increased risk of stroke in elderly patients with dementia-related psychosis, suicidal thoughts or behaviors, and tardive dyskinesia [2]. Patients should discuss any concerns with their healthcare provider.
Where can I find more information on drug patents?
DrugPatentWatch.com provides comprehensive information on drug patents, including expiry dates and patent litigation, for various medications like quetiapine [1].